In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study

Idiotype vaccine therapy (BiovaxID) in follicular lymphoma in first complete remission: Phase III clinical trial results

(2017) S. J. Schuster et al.   JOURNAL OF CLINICAL ONCOLOGY

Generation of CD8+ T cell-mediated immunity against idiotype-negative lymphoma escapees

(2009) B. Varghese et al.   BLOOD

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

(2009) Celestia S. Higano et al.   CANCER

Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma

(2009) A. Ribas et al.   CLINICAL CANCER RESEARCH

Placebo-Controlled Phase III Trial of Patient-Specific Immunotherapy With Mitumprotimut-T and Granulocyte-Macrophage Colony-Stimulating Factor After Rituximab in Patients With Follicular Lymphoma

(2009) Arnold Freedman et al.   JOURNAL OF CLINICAL ONCOLOGY

Idiotype vaccination for lymphoma: moving towards optimisation

(2009) Roch Houot et al.   LEUKEMIA & LYMPHOMA

Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors

(2008) J. D. Brody et al.   BLOOD

Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study

(2008) M. Di Nicola et al.   BLOOD

Local Administration of PF-3512676 CpG-B Instigates Tumor-Specific CD8+ T-Cell Reactivity in Melanoma Patients

(2008) B. G. Molenkamp et al.   CLINICAL CANCER RESEARCH

Randomized clinical studies of anti-tumor vaccination: state of the art in 2008

(2008) Philippe Fournier et al.   Expert Review of Vaccines

Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma

(2008) A. Tzankov et al.   HAEMATOLOGICA

Follicular lymphoma B cells induce the conversion of conventional CD4+T cells to T-regulatory cells

(2008) Weiyun Z. Ai et al.   INTERNATIONAL JOURNAL OF CANCER

Three Phase II Cytokine Working Group Trials of gp100 (210M) Peptide Plus High-Dose Interleukin-2 in Patients With HLA-A2–Positive Advanced Melanoma

(2008) Jeffrey A. Sosman et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase 1 Evaluation of Intralesionally Injected TLR9-agonist PF-3512676 in Patients With Basal Cell Carcinoma or Metastatic Melanoma

(2008) Maja A. Hofmann et al.   JOURNAL OF IMMUNOTHERAPY

Topical CpG Enhances the Response of Murine Malignant Melanoma to Dacarbazine

(2008) Hossain M. Najar et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY